Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy-Reference-Cited by-同舟云学术

Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

Published:2019-12 Issue:12 Volume:25 Page:2305-2321
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Jain Tania,Bar Merav,Kansagra Ankit J.,Chong Elise A.,Hashmi Shahrukh K.,Neelapu Sattva S.,Byrne Michael,Jacoby Elad,Lazaryan Aleksandr,Jacobson Caron A.,Ansell Stephen M.,Awan Farrukh T.^ORCID,Burns Linda,Bachanova Veronika,Bollard Catherine M.,Carpenter Paul A.,DiPersio John F.,Hamadani Mehdi,Heslop Helen E.,Hill Joshua A.,Komanduri Krishna V.,Kovitz Craig A.,Lazarus Hillard M.,Serrette Justin M.,Mohty Mohamad,Miklos David,Nagler Arnon,Pavletic Steven Z.,Savani Bipin N.,Schuster Stephen J.,Kharfan-Dabaja Mohamed A.,Perales Miguel-Angel,Lin Yi

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference100 articles.

1. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017

2. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2019

3. Chimeric antigen receptor therapy;June;N Engl J Med,2018

4. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial;Locke;Lancet Oncol,2019

5. Clinical utilization of chimeric antigen receptor T cells in B cell acute lymphoblastic leukemia: an expert opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation;Kansagra;Biol Blood Marrow Transplant,2019

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lymphocyte recovery after bendamustine therapy in patients with mantle cell lymphoma. Results of a retrospective analysis and prognostic impact in the CAR-T era;Annals of Hematology;2024-08-30

2. Best Practice Considerations by The American Society of Transplant and Cellular Therapy: Infection Prevention and Management After Chimeric Antigen Receptor T Cell Therapy for Hematological Malignancies;Transplantation and Cellular Therapy;2024-07

3. Efficacy and safety of bendamustine‐containing bridging therapy in R/R LBCL patients receiving CD19 CAR T‐cells;HemaSphere;2024-06-26

4. Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review;Targeted Oncology;2024-06-19

5. Novel treatment strategies for hematological malignancies in the immunotherapy era;International Journal of Hematology;2024-06-11